Carregant...
In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition
BACKGROUND: Despite great development in genome and proteome high-throughput methods, treatment failure is a critical point in the management of most solid cancers, including breast cancer (BC). Multiple alternative mechanisms upon drug treatment are involved to offset therapeutic effects, eventuall...
Guardat en:
| Publicat a: | J Transl Med |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989433/ https://ncbi.nlm.nih.gov/pubmed/29871693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1535-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|